Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

The case for semi-mandatory HPV vaccination in China

Nature Biotechnology volume 31, pages 590–591 (2013)Cite this article

Subjects

To the Editor:

The introduction of two human papillomavirus (HPV) vaccines—Merck's (Whitehouse Station, NJ, USA) Gardasil against HPV types 6/11/16/18 or HPV4 and GlaxoSmithKline's (London) Cervarix against HPV types 16/18 or HPV2—for young adult immunizations1,2 represents a major step forward in the prevention of cervical cancer. Since Gardasil was approved in June 2006, HPV vaccination has become the primary prevention strategy for cervical cancer in developed countries. In contrast, many developing countries, including China, have failed to adopt the vaccine largely because of its unprecedented high price ($360 for a three-dose series in the United States)3. The price of the vaccine will likely take years, if not decades, to drop. Similarly, expecting the Global Alliance for Vaccination and Immunization (GAVI) or other global charity organizations to exercise triaged assistance toward worldwide coverage4 and mandatory HPV vaccination is unrealistic, given the staggering level of funding needed and the lengthy political process involved5. As an alternative, we propose a 'semi-mandatory HPV vaccination strategy' in which governments subsidize HPV vaccination initially in low-income settings for high-risk individuals willing to pay an affordable cost. Given the current financial austerity worldwide, the proposed semi-mandatory (initially for high-risk women) vaccination strategy would be more meaningful than a full mandatory vaccination strategy even in high-income countries and/or regions.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Advisory Committee on Immunization Practices. Ann. Intern. Med. 156, 211–217 (2012).

  2. Fryhofer, S.A. Ann. Intern. Med. 156, 243–245 (2012).

    Article  Google Scholar 

  3. Agosti, J.M. & Goldie, S.J. N. Engl. J. Med. 356, 1908–1910 (2007).

    Article  CAS  Google Scholar 

  4. Global Alliance for Vaccines and Immunization (GAVI). <http://www.gavialliance.org/support/apply/countries-eligible-for-support/>. (2012).

  5. Gostin, L.O. J. Am. Med. Assoc. 306, 1699–1700 (2011).

    Article  CAS  Google Scholar 

  6. Clifford, G.M., Smith, J.S., Plummer, M., Muñoz, N. & Franceschi, S. Br. J. Cancer 88, 63–73 (2003).

    Article  CAS  Google Scholar 

  7. International Alliance for Research on Cancer. (IARC, Globocan 2008). <http://globocan.iarc.fr> (2013).

  8. Li, J., Kang, L.N. & Qiao, Y.L. Asian Pac. J. Cancer Prev. 12, 1149–1153 (2011).

    PubMed  Google Scholar 

  9. Li, T.F. et al. Acta Acad. Med. Xinjiang 19, 199–203 (1996).

    Google Scholar 

  10. Tao, L. et al. J. Clin. Exp. Pathol. 26, 397–401 (2010).

    Google Scholar 

  11. WHO Global Health Observatory Data Repository. <http://apps.who.int/gho/data/node.country.country-CHN?lang=en> (2012).

  12. China National Health and Family Planning Commission. <http://www.moh.gov.cn/mohghcws/s3574/201210/56116.shtml> (2012).

  13. Yip, W.C. et al. Lancet 379, 833–842 (2012).

    Article  Google Scholar 

  14. Le Deu, F., Parekh, R., Zhang, F. & Zhou, G. Healthcare in China: Entering uncharted waters. (McKinsey & Co., 2012). <http://www.mckinseychina.com/2012/09/03/healthcare-in-china-entering-uncharted-waters-2/>

    Google Scholar 

  15. Insinga, R.P., Dasbach, E.J. & Elbasha, E.H. Pharmacoeconomics 23, 1107–1122 (2005).

    Article  Google Scholar 

  16. Balabanova, D., McKee, M. & Mills, A. (eds.) 'Good Health at Low Cost' 25 Years On: What Makes a Successful Health System? (London, London School of Hygiene and Tropical Medicine, 2011).

    Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the Ministry of Science and Technology of China (nos. 2009BAI82B02 and 2010DFB34100) and the Oasis Scholar Fund of Shihezi University (no. LZXZ201023). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.

Author information

Authors and Affiliations

  1. Department of Pathology, Shihezi University School of Medicine, Shihezi, Xinjiang, China

    Wen Jie Zhang, Feng Li & Dilixia Simayi

  2. Key Laboratories for Xinjiang Endemic and Ethnic Diseases, Shihezi University School of Medicine, Shihezi, Xinjiang, China

    Wen Jie Zhang, Feng Li & Ying Hong Wang

  3. Obstetrics & Gynecology, Shihezi University School of Medicine, Shihezi, Xinjiang, China

    Ying Hong Wang

  4. Kashi Prefecture Health Bureau, Kashi, Xinjiang, China

    Abudukeyoumu Saimaiti

  5. Kashi Prefecture First People's Hospital, Kashi, Xinjiang, China

    Xiao Guang Zou

  6. Center for Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

    Cheng Liang Xiong

  7. Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

    Fei Li Gong

  8. School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

    Yu Guang Cao

Authors
  1. Wen Jie Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Feng Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ying Hong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dilixia Simayi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Abudukeyoumu Saimaiti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiao Guang Zou
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Cheng Liang Xiong
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Fei Li Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yu Guang Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wen Jie Zhang.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, W., Li, F., Wang, Y. et al. The case for semi-mandatory HPV vaccination in China. Nat Biotechnol 31, 590–591 (2013). https://doi.org/10.1038/nbt.2631

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2631

This article is cited by

Search

Advanced search

Quick links

Nature Briefing Microbiology

Sign up for the Nature Briefing: Microbiology newsletter — what matters in microbiology research, free to your inbox weekly.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing: Microbiology